Antidepressant interactions with warfarin

@article{Duncan1998AntidepressantIW,
  title={Antidepressant interactions with warfarin},
  author={Denise Duncan and Kirtimaan Sayal and Harry W. McConnell and D M Taylor},
  journal={International Clinical Psychopharmacology},
  year={1998},
  volume={13},
  pages={87–94}
}
The interactions between warfarin and antidepressants can have potentially serious consequences resulting from enhanced or reduced anticoagulant activity. Information about such interactions was obtained from a Medline and hand search of the published literature, and by directly contacting manufacturers. The different classes of antidepressants are discussed in turn. The possible mechanisms are considered with particular reference to The cytochrome p450 system. From currently available data on… Expand
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants
TLDR
As CYP3A4 is an important metabolic pathway for all DOACs except dabigatran, it appears reasonable to recommend avoiding the co-prescription of fluoxetine and fluvoxamine and St John’s wort. Expand
Warfarin: pharmacological profile and drug interactions with antidepressants.
TLDR
Of the antidepressants analyzed, those that showed relevant effects on the interaction with warfarin were, in decreasing order: paroxetine, venlafaxine, fluoxETine, and duloxetines. Expand
Psychotropic interactions with warfarin
Objective: Improving knowledge about the cytochrome p450 system means that potential drug interactions can be predicted. Interactions involving warfarin may be thus avoidable. As many patients whoExpand
Clinically Significant Drug Interactions with Newer Antidepressants
TLDR
Although drug interactions with newer antidepressants are potentially, but rarely, clinically significant, the use of antidepressants with a more favourable drug interaction profile is advisable. Expand
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.
TLDR
Second-generation antidepressants are not equivalent in their potential for pharmacokinetic drug interactions and, although interactions may be predictable in specific circumstances, use of an antidepressant with a more favorable drug-interaction profile may be justified. Expand
Drug Interactions Update: Drugs, Herbs, and Oral Anticoagulation
TLDR
The pharmaceutical industry has increased both the number and quality of drug interaction studies prior to marketing new agents, but interactions may still occur in patients, however, despite negative pre-marketing studies in healthy volunteers. Expand
Antidepressants, Warfarin, and the Risk of Hemorrhage
TLDR
The initiation of selective serotonin reuptake inhibitor treatment in patients receiving warfarin was not associated with a significant increase in the risk of hospitalization for upper gastrointestinal tract bleeding (UGIB). Expand
Metabolic drug interactions with new psychotropic agents
TLDR
The potential for metabolically based drug interactions of any new psychotropic agent may be anticipated on the basis of knowledge about the CYP enzymes responsible for its metabolism and about its effect on the activity of these enzymes. Expand
Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors: A Multidatabase Observational Cohort Study
TLDR
Patients concomitantly treated with warfarin and SSRIs that are potent CYP2C9 inhibitors had comparable rates of bleeding events, ischemic or thromboembolic events, and mortality, although small but potentially meaningful effects on bleeding cannot be completely excluded. Expand
THE INFLUENCE OF ETHNICITY AND ANTIDEPRESSANT PHARMACOGENETICS IN THE TREATMENT OF DEPRESSION
TLDR
The CYP isozymes 2D6, 3A4, 1A2 and 2C are discussed in regard to antidepressant drug pharmacokinetics, clinical relevance and variability in activity for each isozyme. Expand
...
1
2
3
4
5
...